Drugs & TargetsFree University of Illinois scientists enter licensing deal with Bayer, Systems Oncology October 02, 2020Vol.46 No.37
Drugs & TargetsFree Elevation Oncology and US Oncology Research collaborate to expand genomic testing of solid tumors October 02, 2020Vol.46 No.37
Clinical RoundupFree Corticosteroids improve survival in critically ill COVID-19 patients October 02, 2020Vol.46 No.37
Clinical RoundupFree Phase III trial shows Opdivo significantly improves DFS as adjuvant therapy for muscle-invasive urothelial carcinoma October 02, 2020Vol.46 No.37
Clinical RoundupFree Yale study reinforces benefit of using targeted therapy for early-stage NSCLC October 02, 2020Vol.46 No.37
FreeTrials & Tribulations The cancer detection rate—a public health approach to early detection October 02, 2020Vol.46 No.37By Joshua J. Ofman and Azra Raza
FreeFunding Opportunities Lymphoma Research Foundation announces $10M initiative for follicular lymphoma clinical research October 02, 2020Vol.46 No.37
FreeFunding Opportunities The Mark Foundation for Cancer Research launches drug discovery partnerships October 02, 2020Vol.46 No.37
FreeIn Brief C. Kent Osborne steps down as director of Dan L Duncan Comprehensive Cancer Center October 02, 2020Vol.46 No.37
FreeIn Brief Ruben Mesa named executive director of the Mays Cancer Center October 02, 2020Vol.46 No.37
